Benefits and Limitations

associated with Cancer-Scan program

The decision to test with PanTum® Detect is a personal one for every individual.

The individual needs to be aware of the limitations and should weigh these against the benefits of annual screening with PanTum® Detect.

BENEFITS

PanTum® Detect is a simple blood test for indications of almost all types of cancer
PanTum® Detect has a high sensitivity of 97.5% (true positives) and specificity of 99% (true negatives) per IVD CE validation study.
PanTum® Detect is suitable for preventive health check and offers screened candidates protection from risk of delay in detection of almost all cancers.
Only those screened candidates who test positive with PanTum® Detect are exposed to standard protocols for early-stage cancer detection pathology & imaging/endoscopy diagnostics
Financial sponsors obtain documented evidence of lower exposure to cancer causing factors to avail adequate “group” health risk financial cover at lower insurance premiums
Annual screening increases the chance of detecting a silently growing tumor in early localized stage/s.

LIMITATIONS

PanTum® Detect is not suitable for individuals with a compromised immune system which has an effect on circulating macrophage numbers.
No screening test provides a result that is 100% accurate or reliable.
As per IVD CE validation study:
- Statistically 1 in 100 candidates screened will receive a false positive result (they don’t have the disease but test positive).
- Statistically 2.5 in 100 candidates with disease will receive false negative result (they do have disease but test negative).
False results are a psychological strain for individuals that get screened with PanTum® Detect.

Connect with us for any queries